documents: FDA-2019-N-5711-0035
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-N-5711-0035 | FDA | FDA-2019-N-5711 | Reference 2 Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs re Importation of Prescription Drugs | Supporting & Related Material | Background Material | 2020-01-06T05:00:00Z | 2020 | 1 | 2020-01-06T20:46:02Z | 0 | 0 | 090000648420d899 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref